Discussion of "The White Paper of the PhRMA Working Group on adaptive dose-ranging designs".
Hemmings
Robert
R
Medicines and Healthcare products Regulatory Agency, UK. robert.hemmings@mhra.gsi.gov.uk
D002986:Clinical Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data; D004305:Dose-Response Relationship, Drug; D004345:Drug Industry; D006801:Humans; D012107:Research Design